|
|
|
Kidney Disease Clinical Trials |
|
Thank you for your interest in clinical trials for Kidney Disease
Please click "Search" to find Kidney Disease clinical trials and medical research studies.
If you receive too many study listings you may enter your zip code to find the locations closest to you.
|
|
|
|
|
Results from Clinical Connection:
|
|
|
|
Your search returned 3 studies:
|
|
|
|
|
Results from other databases:
|
|
Your search returned over 250 results. The top 250 results are being displayed. Please use
additional keywords or decrease the search distance. |
|
Your search returned 250 studies:
- “Nephrology Research BioBank” - NCT00381121-48109
Conditions: Chronic Kidney Disease
Location: Ann Arbor, MI
- 20070360 Incident Dialysis - NCT00803712-
Conditions: Chronic Kidney Disease - Secondary Hyperparathyroidism
Location: Chesapeake, VA
- 30 Week Study of the Combination of ABT-335 and Rosuvastatin Compared to Rosuvastatin Monotherapy for Subjects With Dyslipidemia and Stage 3 Chronic Kidney Disease - NCT00680017-
Conditions: Dyslipidemias - Coronary Heart Disease - Kidney Disease
Location: Oklahoma City, OK
- 30 Week Study of the Combination of ABT-335 and Rosuvastatin Compared to Rosuvastatin Monotherapy for Subjects With Dyslipidemia and Stage 3 Chronic Kidney Disease - NCT00680017-01107A
Conditions: Dyslipidemias - Coronary Heart Disease - Kidney Disease
Location: Springfield, MA
- 30 Week Study of the Combination of ABT-335 and Rosuvastatin Compared to Rosuvastatin Monotherapy for Subjects With Dyslipidemia and Stage 3 Chronic Kidney Disease - NCT00680017-01107B
Conditions: Dyslipidemias - Coronary Heart Disease - Kidney Disease
Location: Springfield, MA
- 30 Week Study of the Combination of ABT-335 and Rosuvastatin Compared to Rosuvastatin Monotherapy for Subjects With Dyslipidemia and Stage 3 Chronic Kidney Disease - NCT00680017-02720
Conditions: Dyslipidemias - Coronary Heart Disease - Kidney Disease
Location: Fall River, MA
- 30 Week Study of the Combination of ABT-335 and Rosuvastatin Compared to Rosuvastatin Monotherapy for Subjects With Dyslipidemia and Stage 3 Chronic Kidney Disease - NCT00680017-02904
Conditions: Dyslipidemias - Coronary Heart Disease - Kidney Disease
Location: Providence, RI
- 30 Week Study of the Combination of ABT-335 and Rosuvastatin Compared to Rosuvastatin Monotherapy for Subjects With Dyslipidemia and Stage 3 Chronic Kidney Disease - NCT00680017-04210
Conditions: Dyslipidemias - Coronary Heart Disease - Kidney Disease
Location: Auburn, ME
- 30 Week Study of the Combination of ABT-335 and Rosuvastatin Compared to Rosuvastatin Monotherapy for Subjects With Dyslipidemia and Stage 3 Chronic Kidney Disease - NCT00680017-07202
Conditions: Dyslipidemias - Coronary Heart Disease - Kidney Disease
Location: Elizabeth, NJ
- 30 Week Study of the Combination of ABT-335 and Rosuvastatin Compared to Rosuvastatin Monotherapy for Subjects With Dyslipidemia and Stage 3 Chronic Kidney Disease - NCT00680017-08009
Conditions: Dyslipidemias - Coronary Heart Disease - Kidney Disease
Location: Berlin, NJ
- 30 Week Study of the Combination of ABT-335 and Rosuvastatin Compared to Rosuvastatin Monotherapy for Subjects With Dyslipidemia and Stage 3 Chronic Kidney Disease - NCT00680017-08844
Conditions: Dyslipidemias - Coronary Heart Disease - Kidney Disease
Location: Hillsborough, NJ
- 30 Week Study of the Combination of ABT-335 and Rosuvastatin Compared to Rosuvastatin Monotherapy for Subjects With Dyslipidemia and Stage 3 Chronic Kidney Disease - NCT00680017-11021
Conditions: Dyslipidemias - Coronary Heart Disease - Kidney Disease
Location: Great Neck, NY
- 30 Week Study of the Combination of ABT-335 and Rosuvastatin Compared to Rosuvastatin Monotherapy for Subjects With Dyslipidemia and Stage 3 Chronic Kidney Disease - NCT00680017-11042
Conditions: Dyslipidemias - Coronary Heart Disease - Kidney Disease
Location: Lake Success, NY
- 30 Week Study of the Combination of ABT-335 and Rosuvastatin Compared to Rosuvastatin Monotherapy for Subjects With Dyslipidemia and Stage 3 Chronic Kidney Disease - NCT00680017-11355
Conditions: Dyslipidemias - Coronary Heart Disease - Kidney Disease
Location: Flushing, NY
- 30 Week Study of the Combination of ABT-335 and Rosuvastatin Compared to Rosuvastatin Monotherapy for Subjects With Dyslipidemia and Stage 3 Chronic Kidney Disease - NCT00680017-14221
Conditions: Dyslipidemias - Coronary Heart Disease - Kidney Disease
Location: Williamsville, NY
- 30 Week Study of the Combination of ABT-335 and Rosuvastatin Compared to Rosuvastatin Monotherapy for Subjects With Dyslipidemia and Stage 3 Chronic Kidney Disease - NCT00680017-15904
Conditions: Dyslipidemias - Coronary Heart Disease - Kidney Disease
Location: Johnstown, PA
- 30 Week Study of the Combination of ABT-335 and Rosuvastatin Compared to Rosuvastatin Monotherapy for Subjects With Dyslipidemia and Stage 3 Chronic Kidney Disease - NCT00680017-16635
Conditions: Dyslipidemias - Coronary Heart Disease - Kidney Disease
Location: Duncansville, PA
- 30 Week Study of the Combination of ABT-335 and Rosuvastatin Compared to Rosuvastatin Monotherapy for Subjects With Dyslipidemia and Stage 3 Chronic Kidney Disease - NCT00680017-16684
Conditions: Dyslipidemias - Coronary Heart Disease - Kidney Disease
Location: Tipton, PA
- 30 Week Study of the Combination of ABT-335 and Rosuvastatin Compared to Rosuvastatin Monotherapy for Subjects With Dyslipidemia and Stage 3 Chronic Kidney Disease - NCT00680017-16933
Conditions: Dyslipidemias - Coronary Heart Disease - Kidney Disease
Location: Mansfield, PA
- 30 Week Study of the Combination of ABT-335 and Rosuvastatin Compared to Rosuvastatin Monotherapy for Subjects With Dyslipidemia and Stage 3 Chronic Kidney Disease - NCT00680017-17015
Conditions: Dyslipidemias - Coronary Heart Disease - Kidney Disease
Location: Carlisle, PA
- 30 Week Study of the Combination of ABT-335 and Rosuvastatin Compared to Rosuvastatin Monotherapy for Subjects With Dyslipidemia and Stage 3 Chronic Kidney Disease - NCT00680017-17740
Conditions: Dyslipidemias - Coronary Heart Disease - Kidney Disease
Location: Jersey Shore, PA
- 30 Week Study of the Combination of ABT-335 and Rosuvastatin Compared to Rosuvastatin Monotherapy for Subjects With Dyslipidemia and Stage 3 Chronic Kidney Disease - NCT00680017-18103
Conditions: Dyslipidemias - Coronary Heart Disease - Kidney Disease
Location: Allentown, PA
- 30 Week Study of the Combination of ABT-335 and Rosuvastatin Compared to Rosuvastatin Monotherapy for Subjects With Dyslipidemia and Stage 3 Chronic Kidney Disease - NCT00680017-18944
Conditions: Dyslipidemias - Coronary Heart Disease - Kidney Disease
Location: Perkasie, PA
- 30 Week Study of the Combination of ABT-335 and Rosuvastatin Compared to Rosuvastatin Monotherapy for Subjects With Dyslipidemia and Stage 3 Chronic Kidney Disease - NCT00680017-18974
Conditions: Dyslipidemias - Coronary Heart Disease - Kidney Disease
Location: Warminster, PA
- 30 Week Study of the Combination of ABT-335 and Rosuvastatin Compared to Rosuvastatin Monotherapy for Subjects With Dyslipidemia and Stage 3 Chronic Kidney Disease - NCT00680017-19107
Conditions: Dyslipidemias - Coronary Heart Disease - Kidney Disease
Location: Philadelphia, PA
- 30 Week Study of the Combination of ABT-335 and Rosuvastatin Compared to Rosuvastatin Monotherapy for Subjects With Dyslipidemia and Stage 3 Chronic Kidney Disease - NCT00680017-19141
Conditions: Dyslipidemias - Coronary Heart Disease - Kidney Disease
Location: Philadelphia, PA
- 30 Week Study of the Combination of ABT-335 and Rosuvastatin Compared to Rosuvastatin Monotherapy for Subjects With Dyslipidemia and Stage 3 Chronic Kidney Disease - NCT00680017-20852
Conditions: Dyslipidemias - Coronary Heart Disease - Kidney Disease
Location: Rockville, MD
- 30 Week Study of the Combination of ABT-335 and Rosuvastatin Compared to Rosuvastatin Monotherapy for Subjects With Dyslipidemia and Stage 3 Chronic Kidney Disease - NCT00680017-21015
Conditions: Dyslipidemias - Coronary Heart Disease - Kidney Disease
Location: Bel Air, MD
- 30 Week Study of the Combination of ABT-335 and Rosuvastatin Compared to Rosuvastatin Monotherapy for Subjects With Dyslipidemia and Stage 3 Chronic Kidney Disease - NCT00680017-21208
Conditions: Dyslipidemias - Coronary Heart Disease - Kidney Disease
Location: Pikesville, MD
- 30 Week Study of the Combination of ABT-335 and Rosuvastatin Compared to Rosuvastatin Monotherapy for Subjects With Dyslipidemia and Stage 3 Chronic Kidney Disease - NCT00680017-28112
Conditions: Dyslipidemias - Coronary Heart Disease - Kidney Disease
Location: Monroe, NC
- 30 Week Study of the Combination of ABT-335 and Rosuvastatin Compared to Rosuvastatin Monotherapy for Subjects With Dyslipidemia and Stage 3 Chronic Kidney Disease - NCT00680017-28208
Conditions: Dyslipidemias - Coronary Heart Disease - Kidney Disease
Location: Charlotte, NC
- 30 Week Study of the Combination of ABT-335 and Rosuvastatin Compared to Rosuvastatin Monotherapy for Subjects With Dyslipidemia and Stage 3 Chronic Kidney Disease - NCT00680017-28277
Conditions: Dyslipidemias - Coronary Heart Disease - Kidney Disease
Location: Charlotte, NC
- 30 Week Study of the Combination of ABT-335 and Rosuvastatin Compared to Rosuvastatin Monotherapy for Subjects With Dyslipidemia and Stage 3 Chronic Kidney Disease - NCT00680017-28557
Conditions: Dyslipidemias - Coronary Heart Disease - Kidney Disease
Location: Morehead City, NC
- 30 Week Study of the Combination of ABT-335 and Rosuvastatin Compared to Rosuvastatin Monotherapy for Subjects With Dyslipidemia and Stage 3 Chronic Kidney Disease - NCT00680017-28626
Conditions: Dyslipidemias - Coronary Heart Disease - Kidney Disease
Location: Charlotte, NC
- 30 Week Study of the Combination of ABT-335 and Rosuvastatin Compared to Rosuvastatin Monotherapy for Subjects With Dyslipidemia and Stage 3 Chronic Kidney Disease - NCT00680017-29209
Conditions: Dyslipidemias - Coronary Heart Disease - Kidney Disease
Location: Columbia, SC
- 30 Week Study of the Combination of ABT-335 and Rosuvastatin Compared to Rosuvastatin Monotherapy for Subjects With Dyslipidemia and Stage 3 Chronic Kidney Disease - NCT00680017-29412
Conditions: Dyslipidemias - Coronary Heart Disease - Kidney Disease
Location: Charleston, SC
- 30 Week Study of the Combination of ABT-335 and Rosuvastatin Compared to Rosuvastatin Monotherapy for Subjects With Dyslipidemia and Stage 3 Chronic Kidney Disease - NCT00680017-29464
Conditions: Dyslipidemias - Coronary Heart Disease - Kidney Disease
Location: Mount Pleasant, SC
- 30 Week Study of the Combination of ABT-335 and Rosuvastatin Compared to Rosuvastatin Monotherapy for Subjects With Dyslipidemia and Stage 3 Chronic Kidney Disease - NCT00680017-29485
Conditions: Dyslipidemias - Coronary Heart Disease - Kidney Disease
Location: Summerville, SC
- 30 Week Study of the Combination of ABT-335 and Rosuvastatin Compared to Rosuvastatin Monotherapy for Subjects With Dyslipidemia and Stage 3 Chronic Kidney Disease - NCT00680017-29605
Conditions: Dyslipidemias - Coronary Heart Disease - Kidney Disease
Location: Greenville, SC
- 30 Week Study of the Combination of ABT-335 and Rosuvastatin Compared to Rosuvastatin Monotherapy for Subjects With Dyslipidemia and Stage 3 Chronic Kidney Disease - NCT00680017-30024
Conditions: Dyslipidemias - Coronary Heart Disease - Kidney Disease
Location: Suwanee, GA
- 30 Week Study of the Combination of ABT-335 and Rosuvastatin Compared to Rosuvastatin Monotherapy for Subjects With Dyslipidemia and Stage 3 Chronic Kidney Disease - NCT00680017-30060
Conditions: Dyslipidemias - Coronary Heart Disease - Kidney Disease
Location: Marietta, GA
- 30 Week Study of the Combination of ABT-335 and Rosuvastatin Compared to Rosuvastatin Monotherapy for Subjects With Dyslipidemia and Stage 3 Chronic Kidney Disease - NCT00680017-30076
Conditions: Dyslipidemias - Coronary Heart Disease - Kidney Disease
Location: Roswell, GA
- 30 Week Study of the Combination of ABT-335 and Rosuvastatin Compared to Rosuvastatin Monotherapy for Subjects With Dyslipidemia and Stage 3 Chronic Kidney Disease - NCT00680017-30331
Conditions: Dyslipidemias - Coronary Heart Disease - Kidney Disease
Location: Atlanta, GA
- 30 Week Study of the Combination of ABT-335 and Rosuvastatin Compared to Rosuvastatin Monotherapy for Subjects With Dyslipidemia and Stage 3 Chronic Kidney Disease - NCT00680017-30338
Conditions: Dyslipidemias - Coronary Heart Disease - Kidney Disease
Location: Dunwoody, GA
- 30 Week Study of the Combination of ABT-335 and Rosuvastatin Compared to Rosuvastatin Monotherapy for Subjects With Dyslipidemia and Stage 3 Chronic Kidney Disease - NCT00680017-31217
Conditions: Dyslipidemias - Coronary Heart Disease - Kidney Disease
Location: Macon, GA
- 30 Week Study of the Combination of ABT-335 and Rosuvastatin Compared to Rosuvastatin Monotherapy for Subjects With Dyslipidemia and Stage 3 Chronic Kidney Disease - NCT00680017-32117
Conditions: Dyslipidemias - Coronary Heart Disease - Kidney Disease
Location: Daytona Beach, FL
- 30 Week Study of the Combination of ABT-335 and Rosuvastatin Compared to Rosuvastatin Monotherapy for Subjects With Dyslipidemia and Stage 3 Chronic Kidney Disease - NCT00680017-32610
Conditions: Dyslipidemias - Coronary Heart Disease - Kidney Disease
Location: Gainesville, FL
- 30 Week Study of the Combination of ABT-335 and Rosuvastatin Compared to Rosuvastatin Monotherapy for Subjects With Dyslipidemia and Stage 3 Chronic Kidney Disease - NCT00680017-32714
Conditions: Dyslipidemias - Coronary Heart Disease - Kidney Disease
Location: Ormond Beach, FL
- 30 Week Study of the Combination of ABT-335 and Rosuvastatin Compared to Rosuvastatin Monotherapy for Subjects With Dyslipidemia and Stage 3 Chronic Kidney Disease - NCT00680017-32779
Conditions: Dyslipidemias - Coronary Heart Disease - Kidney Disease
Location: Longwood, FL
- 30 Week Study of the Combination of ABT-335 and Rosuvastatin Compared to Rosuvastatin Monotherapy for Subjects With Dyslipidemia and Stage 3 Chronic Kidney Disease - NCT00680017-32804
Conditions: Dyslipidemias - Coronary Heart Disease - Kidney Disease
Location: Orlando, FL
- 30 Week Study of the Combination of ABT-335 and Rosuvastatin Compared to Rosuvastatin Monotherapy for Subjects With Dyslipidemia and Stage 3 Chronic Kidney Disease - NCT00680017-32960
Conditions: Dyslipidemias - Coronary Heart Disease - Kidney Disease
Location: Vero Beach, FL
- 30 Week Study of the Combination of ABT-335 and Rosuvastatin Compared to Rosuvastatin Monotherapy for Subjects With Dyslipidemia and Stage 3 Chronic Kidney Disease - NCT00680017-33021
Conditions: Dyslipidemias - Coronary Heart Disease - Kidney Disease
Location: Hollywood, FL
- 30 Week Study of the Combination of ABT-335 and Rosuvastatin Compared to Rosuvastatin Monotherapy for Subjects With Dyslipidemia and Stage 3 Chronic Kidney Disease - NCT00680017-33028
Conditions: Dyslipidemias - Coronary Heart Disease - Kidney Disease
Location: Pembroke Pines, FL
- 30 Week Study of the Combination of ABT-335 and Rosuvastatin Compared to Rosuvastatin Monotherapy for Subjects With Dyslipidemia and Stage 3 Chronic Kidney Disease - NCT00680017-33065
Conditions: Dyslipidemias - Coronary Heart Disease - Kidney Disease
Location: Coral Springs, FL
- 30 Week Study of the Combination of ABT-335 and Rosuvastatin Compared to Rosuvastatin Monotherapy for Subjects With Dyslipidemia and Stage 3 Chronic Kidney Disease - NCT00680017-33313
Conditions: Dyslipidemias - Coronary Heart Disease - Kidney Disease
Location: Lauderdale Lakes, FL
- 30 Week Study of the Combination of ABT-335 and Rosuvastatin Compared to Rosuvastatin Monotherapy for Subjects With Dyslipidemia and Stage 3 Chronic Kidney Disease - NCT00680017-33401
Conditions: Dyslipidemias - Coronary Heart Disease - Kidney Disease
Location: West Palm Beach, FL
- 30 Week Study of the Combination of ABT-335 and Rosuvastatin Compared to Rosuvastatin Monotherapy for Subjects With Dyslipidemia and Stage 3 Chronic Kidney Disease - NCT00680017-33472
Conditions: Dyslipidemias - Coronary Heart Disease - Kidney Disease
Location: Boynton Beach, FL
- 30 Week Study of the Combination of ABT-335 and Rosuvastatin Compared to Rosuvastatin Monotherapy for Subjects With Dyslipidemia and Stage 3 Chronic Kidney Disease - NCT00680017-33563
Conditions: Dyslipidemias - Coronary Heart Disease - Kidney Disease
Location: Plant City, FL
- 30 Week Study of the Combination of ABT-335 and Rosuvastatin Compared to Rosuvastatin Monotherapy for Subjects With Dyslipidemia and Stage 3 Chronic Kidney Disease - NCT00680017-33607
Conditions: Dyslipidemias - Coronary Heart Disease - Kidney Disease
Location: Tampa, FL
- 30 Week Study of the Combination of ABT-335 and Rosuvastatin Compared to Rosuvastatin Monotherapy for Subjects With Dyslipidemia and Stage 3 Chronic Kidney Disease - NCT00680017-33756
Conditions: Dyslipidemias - Coronary Heart Disease - Kidney Disease
Location: Clearwater, FL
- 30 Week Study of the Combination of ABT-335 and Rosuvastatin Compared to Rosuvastatin Monotherapy for Subjects With Dyslipidemia and Stage 3 Chronic Kidney Disease - NCT00680017-33880
Conditions: Dyslipidemias - Coronary Heart Disease - Kidney Disease
Location: Winter Haven, FL
- 30 Week Study of the Combination of ABT-335 and Rosuvastatin Compared to Rosuvastatin Monotherapy for Subjects With Dyslipidemia and Stage 3 Chronic Kidney Disease - NCT00680017-33952
Conditions: Dyslipidemias - Coronary Heart Disease - Kidney Disease
Location: Port Charlotte, FL
- 30 Week Study of the Combination of ABT-335 and Rosuvastatin Compared to Rosuvastatin Monotherapy for Subjects With Dyslipidemia and Stage 3 Chronic Kidney Disease - NCT00680017-34652
Conditions: Dyslipidemias - Coronary Heart Disease - Kidney Disease
Location: New Port Richey, FL
- 30 Week Study of the Combination of ABT-335 and Rosuvastatin Compared to Rosuvastatin Monotherapy for Subjects With Dyslipidemia and Stage 3 Chronic Kidney Disease - NCT00680017-34667
Conditions: Dyslipidemias - Coronary Heart Disease - Kidney Disease
Location: Hudson, FL
- 30 Week Study of the Combination of ABT-335 and Rosuvastatin Compared to Rosuvastatin Monotherapy for Subjects With Dyslipidemia and Stage 3 Chronic Kidney Disease - NCT00680017-34741
Conditions: Dyslipidemias - Coronary Heart Disease - Kidney Disease
Location: Kissimmee, FL
- 30 Week Study of the Combination of ABT-335 and Rosuvastatin Compared to Rosuvastatin Monotherapy for Subjects With Dyslipidemia and Stage 3 Chronic Kidney Disease - NCT00680017-35242
Conditions: Dyslipidemias - Coronary Heart Disease - Kidney Disease
Location: Birmingham, AL
- 30 Week Study of the Combination of ABT-335 and Rosuvastatin Compared to Rosuvastatin Monotherapy for Subjects With Dyslipidemia and Stage 3 Chronic Kidney Disease - NCT00680017-35758
Conditions: Dyslipidemias - Coronary Heart Disease - Kidney Disease
Location: Madison, AL
- 30 Week Study of the Combination of ABT-335 and Rosuvastatin Compared to Rosuvastatin Monotherapy for Subjects With Dyslipidemia and Stage 3 Chronic Kidney Disease - NCT00680017-35801
Conditions: Dyslipidemias - Coronary Heart Disease - Kidney Disease
Location: Huntsville, AL
- 30 Week Study of the Combination of ABT-335 and Rosuvastatin Compared to Rosuvastatin Monotherapy for Subjects With Dyslipidemia and Stage 3 Chronic Kidney Disease - NCT00680017-36106
Conditions: Dyslipidemias - Coronary Heart Disease - Kidney Disease
Location: Montgomery, AL
- 30 Week Study of the Combination of ABT-335 and Rosuvastatin Compared to Rosuvastatin Monotherapy for Subjects With Dyslipidemia and Stage 3 Chronic Kidney Disease - NCT00680017-37130
Conditions: Dyslipidemias - Coronary Heart Disease - Kidney Disease
Location: Murfreesboro, TN
- 30 Week Study of the Combination of ABT-335 and Rosuvastatin Compared to Rosuvastatin Monotherapy for Subjects With Dyslipidemia and Stage 3 Chronic Kidney Disease - NCT00680017-37205
Conditions: Dyslipidemias - Coronary Heart Disease - Kidney Disease
Location: Nashville, TN
- 30 Week Study of the Combination of ABT-335 and Rosuvastatin Compared to Rosuvastatin Monotherapy for Subjects With Dyslipidemia and Stage 3 Chronic Kidney Disease - NCT00680017-38654
Conditions: Dyslipidemias - Coronary Heart Disease - Kidney Disease
Location: Olive Branch, MS
- 30 Week Study of the Combination of ABT-335 and Rosuvastatin Compared to Rosuvastatin Monotherapy for Subjects With Dyslipidemia and Stage 3 Chronic Kidney Disease - NCT00680017-42003
Conditions: Dyslipidemias - Coronary Heart Disease - Kidney Disease
Location: Paducah, KY
- 30 Week Study of the Combination of ABT-335 and Rosuvastatin Compared to Rosuvastatin Monotherapy for Subjects With Dyslipidemia and Stage 3 Chronic Kidney Disease - NCT00680017-43215
Conditions: Dyslipidemias - Coronary Heart Disease - Kidney Disease
Location: Columbus, OH
- 30 Week Study of the Combination of ABT-335 and Rosuvastatin Compared to Rosuvastatin Monotherapy for Subjects With Dyslipidemia and Stage 3 Chronic Kidney Disease - NCT00680017-45040
Conditions: Dyslipidemias - Coronary Heart Disease - Kidney Disease
Location: Mason, OH
- 30 Week Study of the Combination of ABT-335 and Rosuvastatin Compared to Rosuvastatin Monotherapy for Subjects With Dyslipidemia and Stage 3 Chronic Kidney Disease - NCT00680017-45267
Conditions: Dyslipidemias - Coronary Heart Disease - Kidney Disease
Location: Cincinnati, OH
- 30 Week Study of the Combination of ABT-335 and Rosuvastatin Compared to Rosuvastatin Monotherapy for Subjects With Dyslipidemia and Stage 3 Chronic Kidney Disease - NCT00680017-46544
Conditions: Dyslipidemias - Coronary Heart Disease - Kidney Disease
Location: Mishawaka, IN
- 30 Week Study of the Combination of ABT-335 and Rosuvastatin Compared to Rosuvastatin Monotherapy for Subjects With Dyslipidemia and Stage 3 Chronic Kidney Disease - NCT00680017-48073
Conditions: Dyslipidemias - Coronary Heart Disease - Kidney Disease
Location: Royal Oak, MI
- 30 Week Study of the Combination of ABT-335 and Rosuvastatin Compared to Rosuvastatin Monotherapy for Subjects With Dyslipidemia and Stage 3 Chronic Kidney Disease - NCT00680017-51505
Conditions: Dyslipidemias - Coronary Heart Disease - Kidney Disease
Location: Council Bluffs, IA
- 30 Week Study of the Combination of ABT-335 and Rosuvastatin Compared to Rosuvastatin Monotherapy for Subjects With Dyslipidemia and Stage 3 Chronic Kidney Disease - NCT00680017-52242
Conditions: Dyslipidemias - Coronary Heart Disease - Kidney Disease
Location: Iowa City, IA
- 30 Week Study of the Combination of ABT-335 and Rosuvastatin Compared to Rosuvastatin Monotherapy for Subjects With Dyslipidemia and Stage 3 Chronic Kidney Disease - NCT00680017-55430
Conditions: Dyslipidemias - Coronary Heart Disease - Kidney Disease
Location: Brooklyn Center, MN
- 30 Week Study of the Combination of ABT-335 and Rosuvastatin Compared to Rosuvastatin Monotherapy for Subjects With Dyslipidemia and Stage 3 Chronic Kidney Disease - NCT00680017-60504
Conditions: Dyslipidemias - Coronary Heart Disease - Kidney Disease
Location: Aurora, IL
- 30 Week Study of the Combination of ABT-335 and Rosuvastatin Compared to Rosuvastatin Monotherapy for Subjects With Dyslipidemia and Stage 3 Chronic Kidney Disease - NCT00680017-60616
Conditions: Dyslipidemias - Coronary Heart Disease - Kidney Disease
Location: Chicago, IL
- 30 Week Study of the Combination of ABT-335 and Rosuvastatin Compared to Rosuvastatin Monotherapy for Subjects With Dyslipidemia and Stage 3 Chronic Kidney Disease - NCT00680017-61603
Conditions: Dyslipidemias - Coronary Heart Disease - Kidney Disease
Location: Peoria, IL
- 30 Week Study of the Combination of ABT-335 and Rosuvastatin Compared to Rosuvastatin Monotherapy for Subjects With Dyslipidemia and Stage 3 Chronic Kidney Disease - NCT00680017-70121
Conditions: Dyslipidemias - Coronary Heart Disease - Kidney Disease
Location: New Orleans, LA
- 30 Week Study of the Combination of ABT-335 and Rosuvastatin Compared to Rosuvastatin Monotherapy for Subjects With Dyslipidemia and Stage 3 Chronic Kidney Disease - NCT00680017-71101
Conditions: Dyslipidemias - Coronary Heart Disease - Kidney Disease
Location: Shreveport, LA
- 30 Week Study of the Combination of ABT-335 and Rosuvastatin Compared to Rosuvastatin Monotherapy for Subjects With Dyslipidemia and Stage 3 Chronic Kidney Disease - NCT00680017-71901
Conditions: Dyslipidemias - Coronary Heart Disease - Kidney Disease
Location: Hot Springs, AR
- 30 Week Study of the Combination of ABT-335 and Rosuvastatin Compared to Rosuvastatin Monotherapy for Subjects With Dyslipidemia and Stage 3 Chronic Kidney Disease - NCT00680017-73103
Conditions: Dyslipidemias - Coronary Heart Disease - Kidney Disease
Location: Oklahoma City, OK
- 30 Week Study of the Combination of ABT-335 and Rosuvastatin Compared to Rosuvastatin Monotherapy for Subjects With Dyslipidemia and Stage 3 Chronic Kidney Disease - NCT00680017-74136
Conditions: Dyslipidemias - Coronary Heart Disease - Kidney Disease
Location: Tulsa, OK
- 30 Week Study of the Combination of ABT-335 and Rosuvastatin Compared to Rosuvastatin Monotherapy for Subjects With Dyslipidemia and Stage 3 Chronic Kidney Disease - NCT00680017-75050
Conditions: Dyslipidemias - Coronary Heart Disease - Kidney Disease
Location: Grand Prairie, TX
- 30 Week Study of the Combination of ABT-335 and Rosuvastatin Compared to Rosuvastatin Monotherapy for Subjects With Dyslipidemia and Stage 3 Chronic Kidney Disease - NCT00680017-75251
Conditions: Dyslipidemias - Coronary Heart Disease - Kidney Disease
Location: Dallas, TX
- 30 Week Study of the Combination of ABT-335 and Rosuvastatin Compared to Rosuvastatin Monotherapy for Subjects With Dyslipidemia and Stage 3 Chronic Kidney Disease - NCT00680017-76104
Conditions: Dyslipidemias - Coronary Heart Disease - Kidney Disease
Location: Fort Worth, TX
- 30 Week Study of the Combination of ABT-335 and Rosuvastatin Compared to Rosuvastatin Monotherapy for Subjects With Dyslipidemia and Stage 3 Chronic Kidney Disease - NCT00680017-77005
Conditions: Dyslipidemias - Coronary Heart Disease - Kidney Disease
Location: Houston, TX
- 30 Week Study of the Combination of ABT-335 and Rosuvastatin Compared to Rosuvastatin Monotherapy for Subjects With Dyslipidemia and Stage 3 Chronic Kidney Disease - NCT00680017-77024
Conditions: Dyslipidemias - Coronary Heart Disease - Kidney Disease
Location: Houston, TX
- 30 Week Study of the Combination of ABT-335 and Rosuvastatin Compared to Rosuvastatin Monotherapy for Subjects With Dyslipidemia and Stage 3 Chronic Kidney Disease - NCT00680017-77030
Conditions: Dyslipidemias - Coronary Heart Disease - Kidney Disease
Location: Houston, TX
- 30 Week Study of the Combination of ABT-335 and Rosuvastatin Compared to Rosuvastatin Monotherapy for Subjects With Dyslipidemia and Stage 3 Chronic Kidney Disease - NCT00680017-77074
Conditions: Dyslipidemias - Coronary Heart Disease - Kidney Disease
Location: Houston, TX
- 30 Week Study of the Combination of ABT-335 and Rosuvastatin Compared to Rosuvastatin Monotherapy for Subjects With Dyslipidemia and Stage 3 Chronic Kidney Disease - NCT00680017-78207
Conditions: Dyslipidemias - Coronary Heart Disease - Kidney Disease
Location: San Antonio, TX
- 30 Week Study of the Combination of ABT-335 and Rosuvastatin Compared to Rosuvastatin Monotherapy for Subjects With Dyslipidemia and Stage 3 Chronic Kidney Disease - NCT00680017-78224
Conditions: Dyslipidemias - Coronary Heart Disease - Kidney Disease
Location: San Antonio, TX
- 30 Week Study of the Combination of ABT-335 and Rosuvastatin Compared to Rosuvastatin Monotherapy for Subjects With Dyslipidemia and Stage 3 Chronic Kidney Disease - NCT00680017-78539
Conditions: Dyslipidemias - Coronary Heart Disease - Kidney Disease
Location: Edinburg, TX
- 30 Week Study of the Combination of ABT-335 and Rosuvastatin Compared to Rosuvastatin Monotherapy for Subjects With Dyslipidemia and Stage 3 Chronic Kidney Disease - NCT00680017-79410
Conditions: Dyslipidemias - Coronary Heart Disease - Kidney Disease
Location: Lubbock, TX
- 30 Week Study of the Combination of ABT-335 and Rosuvastatin Compared to Rosuvastatin Monotherapy for Subjects With Dyslipidemia and Stage 3 Chronic Kidney Disease - NCT00680017-80031
Conditions: Dyslipidemias - Coronary Heart Disease - Kidney Disease
Location: Westminster, CO
- 30 Week Study of the Combination of ABT-335 and Rosuvastatin Compared to Rosuvastatin Monotherapy for Subjects With Dyslipidemia and Stage 3 Chronic Kidney Disease - NCT00680017-80214
Conditions: Dyslipidemias - Coronary Heart Disease - Kidney Disease
Location: Lakewood, CO
- 30 Week Study of the Combination of ABT-335 and Rosuvastatin Compared to Rosuvastatin Monotherapy for Subjects With Dyslipidemia and Stage 3 Chronic Kidney Disease - NCT00680017-80260
Conditions: Dyslipidemias - Coronary Heart Disease - Kidney Disease
Location: Thorton, CO
- 30 Week Study of the Combination of ABT-335 and Rosuvastatin Compared to Rosuvastatin Monotherapy for Subjects With Dyslipidemia and Stage 3 Chronic Kidney Disease - NCT00680017-84124
Conditions: Dyslipidemias - Coronary Heart Disease - Kidney Disease
Location: Salt Lake City, UT
- 30 Week Study of the Combination of ABT-335 and Rosuvastatin Compared to Rosuvastatin Monotherapy for Subjects With Dyslipidemia and Stage 3 Chronic Kidney Disease - NCT00680017-84403
Conditions: Dyslipidemias - Coronary Heart Disease - Kidney Disease
Location: Ogden, UT
- 30 Week Study of the Combination of ABT-335 and Rosuvastatin Compared to Rosuvastatin Monotherapy for Subjects With Dyslipidemia and Stage 3 Chronic Kidney Disease - NCT00680017-90048
Conditions: Dyslipidemias - Coronary Heart Disease - Kidney Disease
Location: Los Angeles, CA
- 30 Week Study of the Combination of ABT-335 and Rosuvastatin Compared to Rosuvastatin Monotherapy for Subjects With Dyslipidemia and Stage 3 Chronic Kidney Disease - NCT00680017-90073
Conditions: Dyslipidemias - Coronary Heart Disease - Kidney Disease
Location: Los Angeles, CA
- 30 Week Study of the Combination of ABT-335 and Rosuvastatin Compared to Rosuvastatin Monotherapy for Subjects With Dyslipidemia and Stage 3 Chronic Kidney Disease - NCT00680017-90650
Conditions: Dyslipidemias - Coronary Heart Disease - Kidney Disease
Location: Norwalk, CA
- 30 Week Study of the Combination of ABT-335 and Rosuvastatin Compared to Rosuvastatin Monotherapy for Subjects With Dyslipidemia and Stage 3 Chronic Kidney Disease - NCT00680017-90806
Conditions: Dyslipidemias - Coronary Heart Disease - Kidney Disease
Location: Long Beach, CA
- 30 Week Study of the Combination of ABT-335 and Rosuvastatin Compared to Rosuvastatin Monotherapy for Subjects With Dyslipidemia and Stage 3 Chronic Kidney Disease - NCT00680017-91204
Conditions: Dyslipidemias - Coronary Heart Disease - Kidney Disease
Location: Glendale, CA
- 30 Week Study of the Combination of ABT-335 and Rosuvastatin Compared to Rosuvastatin Monotherapy for Subjects With Dyslipidemia and Stage 3 Chronic Kidney Disease - NCT00680017-91307
Conditions: Dyslipidemias - Coronary Heart Disease - Kidney Disease
Location: West Hills, CA
- 30 Week Study of the Combination of ABT-335 and Rosuvastatin Compared to Rosuvastatin Monotherapy for Subjects With Dyslipidemia and Stage 3 Chronic Kidney Disease - NCT00680017-91910
Conditions: Dyslipidemias - Coronary Heart Disease - Kidney Disease
Location: Chula Vista, CA
- 30 Week Study of the Combination of ABT-335 and Rosuvastatin Compared to Rosuvastatin Monotherapy for Subjects With Dyslipidemia and Stage 3 Chronic Kidney Disease - NCT00680017-91942
Conditions: Dyslipidemias - Coronary Heart Disease - Kidney Disease
Location: La Mesa, CA
- 30 Week Study of the Combination of ABT-335 and Rosuvastatin Compared to Rosuvastatin Monotherapy for Subjects With Dyslipidemia and Stage 3 Chronic Kidney Disease - NCT00680017-92123
Conditions: Dyslipidemias - Coronary Heart Disease - Kidney Disease
Location: San Diego, CA
- 30 Week Study of the Combination of ABT-335 and Rosuvastatin Compared to Rosuvastatin Monotherapy for Subjects With Dyslipidemia and Stage 3 Chronic Kidney Disease - NCT00680017-92505
Conditions: Dyslipidemias - Coronary Heart Disease - Kidney Disease
Location: Riverside, CA
- 30 Week Study of the Combination of ABT-335 and Rosuvastatin Compared to Rosuvastatin Monotherapy for Subjects With Dyslipidemia and Stage 3 Chronic Kidney Disease - NCT00680017-92708
Conditions: Dyslipidemias - Coronary Heart Disease - Kidney Disease
Location: Fountain Valley, CA
- 30 Week Study of the Combination of ABT-335 and Rosuvastatin Compared to Rosuvastatin Monotherapy for Subjects With Dyslipidemia and Stage 3 Chronic Kidney Disease - NCT00680017-93065
Conditions: Dyslipidemias - Coronary Heart Disease - Kidney Disease
Location: Simi Valley, CA
- 30 Week Study of the Combination of ABT-335 and Rosuvastatin Compared to Rosuvastatin Monotherapy for Subjects With Dyslipidemia and Stage 3 Chronic Kidney Disease - NCT00680017-95661
Conditions: Dyslipidemias - Coronary Heart Disease - Kidney Disease
Location: Roseville, CA
- 30 Week Study of the Combination of ABT-335 and Rosuvastatin Compared to Rosuvastatin Monotherapy for Subjects With Dyslipidemia and Stage 3 Chronic Kidney Disease - NCT00680017-95825
Conditions: Dyslipidemias - Coronary Heart Disease - Kidney Disease
Location: Sacramento, CA
- 30 Week Study of the Combination of ABT-335 and Rosuvastatin Compared to Rosuvastatin Monotherapy for Subjects With Dyslipidemia and Stage 3 Chronic Kidney Disease - NCT00680017-97210
Conditions: Dyslipidemias - Coronary Heart Disease - Kidney Disease
Location: Portland, OR
- 30 Week Study of the Combination of ABT-335 and Rosuvastatin Compared to Rosuvastatin Monotherapy for Subjects With Dyslipidemia and Stage 3 Chronic Kidney Disease - NCT00680017-97504
Conditions: Dyslipidemias - Coronary Heart Disease - Kidney Disease
Location: Medford, OR
- 30 Week Study of the Combination of ABT-335 and Rosuvastatin Compared to Rosuvastatin Monotherapy for Subjects With Dyslipidemia and Stage 3 Chronic Kidney Disease - NCT00680017-97701
Conditions: Dyslipidemias - Coronary Heart Disease - Kidney Disease
Location: Bend, OR
- 30 Week Study of the Combination of ABT-335 and Rosuvastatin Compared to Rosuvastatin Monotherapy for Subjects With Dyslipidemia and Stage 3 Chronic Kidney Disease - NCT00680017-98335
Conditions: Dyslipidemias - Coronary Heart Disease - Kidney Disease
Location: Gig Harbor, WA
- 30 Week Study of the Combination of ABT-335 and Rosuvastatin Compared to Rosuvastatin Monotherapy for Subjects With Dyslipidemia and Stage 3 Chronic Kidney Disease - NCT00680017-98405
Conditions: Dyslipidemias - Coronary Heart Disease - Kidney Disease
Location: Tacoma, WA
- 30 Week Study of the Combination of ABT-335 and Rosuvastatin Compared to Rosuvastatin Monotherapy for Subjects With Dyslipidemia and Stage 3 Chronic Kidney Disease - NCT00680017-98665
Conditions: Dyslipidemias - Coronary Heart Disease - Kidney Disease
Location: Vancouver, WA
- A Clinical Trial of Oral Versus IV Iron in Patients With Chronic Kidney Disease - NCT00830037-46202
Conditions: Chronic Kidney Disease - Iron-Deficiency Anemia
Location: Indianapolis, IN
- A Comparative Study to Assess the Differences in Kidney Structure and Function Between Young Kidney Donors Aged 18 to 45 Years and Older Kidney Donors Aged 55 Years and Above Before and After Kidney Donation for Transplantation. - NCT00846729-94305
Conditions: Kidney Diseases
Location: Stanford, CA
- A Double Blind Randomized Placebo Trial of Maintenance of Normal Serum Phosphorus in CKD - NCT00785629-80230
Conditions: Chronic Kidney Disease
Location: Denver, CO
- A Phase 1-2 Study of PRT-201 Administered in Chronic Kidney Disease (CKD) Patients - NCT00679991-01104
Conditions: Chronic Kidney Disease
Location: Springfield, MA
- A Phase 1-2 Study of PRT-201 Administered in Chronic Kidney Disease (CKD) Patients - NCT00679991-02115
Conditions: Chronic Kidney Disease
Location: Boston, MA
- A Phase 1-2 Study of PRT-201 Administered in Chronic Kidney Disease (CKD) Patients - NCT00679991-04102
Conditions: Chronic Kidney Disease
Location: Portland, ME
- A Phase 1-2 Study of PRT-201 Administered in Chronic Kidney Disease (CKD) Patients - NCT00679991-10065
Conditions: Chronic Kidney Disease
Location: New York, NY
- A Phase 1-2 Study of PRT-201 Administered in Chronic Kidney Disease (CKD) Patients - NCT00679991-23507
Conditions: Chronic Kidney Disease
Location: Norfolk, VA
- A Phase 1-2 Study of PRT-201 Administered in Chronic Kidney Disease (CKD) Patients - NCT00679991-27710
Conditions: Chronic Kidney Disease
Location: Durham, NC
- A Phase 1-2 Study of PRT-201 Administered in Chronic Kidney Disease (CKD) Patients - NCT00679991-45267
Conditions: Chronic Kidney Disease
Location: Cincinnati, OH
- A Phase 1-2 Study of PRT-201 Administered in Chronic Kidney Disease (CKD) Patients - NCT00679991-46202
Conditions: Chronic Kidney Disease
Location: Indianapolis, IN
- A Phase 1-2 Study of PRT-201 Administered in Chronic Kidney Disease (CKD) Patients - NCT00679991-52242
Conditions: Chronic Kidney Disease
Location: Iowa City, IA
- A Phase 1-2 Study of PRT-201 Administered in Chronic Kidney Disease (CKD) Patients - NCT00679991-63110
Conditions: Chronic Kidney Disease
Location: St. Louis, MO
- A Phase 1-2 Study of PRT-201 Administered in Chronic Kidney Disease (CKD) Patients - NCT00679991-77030
Conditions: Chronic Kidney Disease
Location: Houston, TX
- A Study in Patients With Diabetic Kidney Disease - NCT01113801-02904
Conditions: Diabetic Kidney Disease - Diabetic Nephropathy - Diabetic Glomerulosclerosis
Location: Providence, RI
- A Study in Patients With Diabetic Kidney Disease - NCT01113801-11212
Conditions: Diabetic Kidney Disease - Diabetic Nephropathy - Diabetic Glomerulosclerosis
Location: Brooklyn, NY
- A Study in Patients With Diabetic Kidney Disease - NCT01113801-11768
Conditions: Diabetic Kidney Disease - Diabetic Nephropathy - Diabetic Glomerulosclerosis
Location: Northport, NY
- A Study in Patients With Diabetic Kidney Disease - NCT01113801-14215
Conditions: Diabetic Kidney Disease - Diabetic Nephropathy - Diabetic Glomerulosclerosis
Location: Buffalo, NY
- A Study in Patients With Diabetic Kidney Disease - NCT01113801-19104
Conditions: Diabetic Kidney Disease - Diabetic Nephropathy - Diabetic Glomerulosclerosis
Location: Philadelphia, PA
- A Study in Patients With Diabetic Kidney Disease - NCT01113801-22908
Conditions: Diabetic Kidney Disease - Diabetic Nephropathy - Diabetic Glomerulosclerosis
Location: Charlottesville, VA
- A Study in Patients With Diabetic Kidney Disease - NCT01113801-27157
Conditions: Diabetic Kidney Disease - Diabetic Nephropathy - Diabetic Glomerulosclerosis
Location: Winston-Salem, NC
- A Study in Patients With Diabetic Kidney Disease - NCT01113801-27599
Conditions: Diabetic Kidney Disease - Diabetic Nephropathy - Diabetic Glomerulosclerosis
Location: Chapel Hill, NC
- A Study in Patients With Diabetic Kidney Disease - NCT01113801-27705
Conditions: Diabetic Kidney Disease - Diabetic Nephropathy - Diabetic Glomerulosclerosis
Location: Durham, NC
- A Study in Patients With Diabetic Kidney Disease - NCT01113801-30030
Conditions: Diabetic Kidney Disease - Diabetic Nephropathy - Diabetic Glomerulosclerosis
Location: Decatur, GA
- A Study in Patients With Diabetic Kidney Disease - NCT01113801-33401
Conditions: Diabetic Kidney Disease - Diabetic Nephropathy - Diabetic Glomerulosclerosis
Location: West Palm Beach, FL
- A Study in Patients With Diabetic Kidney Disease - NCT01113801-37232
Conditions: Diabetic Kidney Disease - Diabetic Nephropathy - Diabetic Glomerulosclerosis
Location: Nashville, TN
- A Study in Patients With Diabetic Kidney Disease - NCT01113801-44060
Conditions: Diabetic Kidney Disease - Diabetic Nephropathy - Diabetic Glomerulosclerosis
Location: Mentor, OH
- A Study in Patients With Diabetic Kidney Disease - NCT01113801-44122
Conditions: Diabetic Kidney Disease - Diabetic Nephropathy - Diabetic Glomerulosclerosis
Location: Beachwood, OH
- A Study in Patients With Diabetic Kidney Disease - NCT01113801-44195
Conditions: Diabetic Kidney Disease - Diabetic Nephropathy - Diabetic Glomerulosclerosis
Location: Cleveland, OH
- A Study in Patients With Diabetic Kidney Disease - NCT01113801-53295
Conditions: Diabetic Kidney Disease - Diabetic Nephropathy - Diabetic Glomerulosclerosis
Location: Milwaukee, WI
- A Study in Patients With Diabetic Kidney Disease - NCT01113801-60607
Conditions: Diabetic Kidney Disease - Diabetic Nephropathy - Diabetic Glomerulosclerosis
Location: Chicago, IL
- A Study in Patients With Diabetic Kidney Disease - NCT01113801-64128
Conditions: Diabetic Kidney Disease - Diabetic Nephropathy - Diabetic Glomerulosclerosis
Location: Kansas City, MO
- A Study in Patients With Diabetic Kidney Disease - NCT01113801-68131
Conditions: Diabetic Kidney Disease - Diabetic Nephropathy - Diabetic Glomerulosclerosis
Location: Omaha, NE
- A Study in Patients With Diabetic Kidney Disease - NCT01113801-70065
Conditions: Diabetic Kidney Disease - Diabetic Nephropathy - Diabetic Glomerulosclerosis
Location: Kenner, LA
- A Study in Patients With Diabetic Kidney Disease - NCT01113801-75390
Conditions: Diabetic Kidney Disease - Diabetic Nephropathy - Diabetic Glomerulosclerosis
Location: Dallas, TX
- A Study in Patients With Diabetic Kidney Disease - NCT01113801-78229
Conditions: Diabetic Kidney Disease - Diabetic Nephropathy - Diabetic Glomerulosclerosis
Location: San Antonio, TX
- A Study in Patients With Diabetic Kidney Disease - NCT01113801-80002
Conditions: Diabetic Kidney Disease - Diabetic Nephropathy - Diabetic Glomerulosclerosis
Location: Arvada, CO
- A Study in Patients With Diabetic Kidney Disease - NCT01113801-80031
Conditions: Diabetic Kidney Disease - Diabetic Nephropathy - Diabetic Glomerulosclerosis
Location: Westminster, CO
- A Study in Patients With Diabetic Kidney Disease - NCT01113801-80220
Conditions: Diabetic Kidney Disease - Diabetic Nephropathy - Diabetic Glomerulosclerosis
Location: Denver, CO
- A Study in Patients With Diabetic Kidney Disease - NCT01113801-83404
Conditions: Diabetic Kidney Disease - Diabetic Nephropathy - Diabetic Glomerulosclerosis
Location: Idaho Falls, ID
- A Study in Patients With Diabetic Kidney Disease - NCT01113801-85012
Conditions: Diabetic Kidney Disease - Diabetic Nephropathy - Diabetic Glomerulosclerosis
Location: Phoenix, AZ
- A Study in Patients With Diabetic Kidney Disease - NCT01113801-85723
Conditions: Diabetic Kidney Disease - Diabetic Nephropathy - Diabetic Glomerulosclerosis
Location: Tucson, AZ
- A Study in Patients With Diabetic Kidney Disease - NCT01113801-89129
Conditions: Diabetic Kidney Disease - Diabetic Nephropathy - Diabetic Glomerulosclerosis
Location: Las Vegas, NV
- A Study in Patients With Diabetic Kidney Disease - NCT01113801-90073
Conditions: Diabetic Kidney Disease - Diabetic Nephropathy - Diabetic Glomerulosclerosis
Location: Los Angeles, CA
- A Study of PRT-201 Administered After Arteriovenous Graft (AVG) Creation in Patients With Chronic Kidney Disease - NCT01001351-10065
Conditions: Chronic Kidney Disease
Location: New York, NY
- A Study of PRT-201 Administered After Arteriovenous Graft (AVG) Creation in Patients With Chronic Kidney Disease - NCT01001351-23507
Conditions: Chronic Kidney Disease
Location: Norfolk, VA
- A Study of PRT-201 Administered After Arteriovenous Graft (AVG) Creation in Patients With Chronic Kidney Disease - NCT01001351-27710
Conditions: Chronic Kidney Disease
Location: Durham, NC
- A Study of PRT-201 Administered After Arteriovenous Graft (AVG) Creation in Patients With Chronic Kidney Disease - NCT01001351-45267
Conditions: Chronic Kidney Disease
Location: Cincinnati, OH
- A Study of PRT-201 Administered After Arteriovenous Graft (AVG) Creation in Patients With Chronic Kidney Disease - NCT01001351-46202
Conditions: Chronic Kidney Disease
Location: Indianapolis, IN
- A Study of PRT-201 Administered After Arteriovenous Graft (AVG) Creation in Patients With Chronic Kidney Disease - NCT01001351-48507
Conditions: Chronic Kidney Disease
Location: Flint, MI
- A Study of PRT-201 Administered After Arteriovenous Graft (AVG) Creation in Patients With Chronic Kidney Disease - NCT01001351-78205
Conditions: Chronic Kidney Disease
Location: San Antonio, TX
- A Study of Subcutaneous Mircera in Patients With Chronic Kidney Disease, Not on Dialysis. - NCT00442702-02903
Conditions: Anemia
Location: Providence, RI
- A Study of Subcutaneous Mircera in Patients With Chronic Kidney Disease, Not on Dialysis. - NCT00442702-11501
Conditions: Anemia
Location: Mineola, NY
- A Study of Subcutaneous Mircera in Patients With Chronic Kidney Disease, Not on Dialysis. - NCT00442702-14127
Conditions: Anemia
Location: Orchard Park, NY
- A Study of Subcutaneous Mircera in Patients With Chronic Kidney Disease, Not on Dialysis. - NCT00442702-24153
Conditions: Anemia
Location: Salem, VA
- A Study of Subcutaneous Mircera in Patients With Chronic Kidney Disease, Not on Dialysis. - NCT00442702-26506
Conditions: Anemia
Location: Morgantown, WV
- A Study of Subcutaneous Mircera in Patients With Chronic Kidney Disease, Not on Dialysis. - NCT00442702-27609
Conditions: Anemia
Location: Raleigh, NC
- A Study of Subcutaneous Mircera in Patients With Chronic Kidney Disease, Not on Dialysis. - NCT00442702-30901
Conditions: Anemia
Location: Augusta, GA
- A Study of Subcutaneous Mircera in Patients With Chronic Kidney Disease, Not on Dialysis. - NCT00442702-33313
Conditions: Anemia
Location: Lauderdale Lakes, FL
- A Study of Subcutaneous Mircera in Patients With Chronic Kidney Disease, Not on Dialysis. - NCT00442702-37404
Conditions: Anemia
Location: Chattanooga, TN
- A Study of Subcutaneous Mircera in Patients With Chronic Kidney Disease, Not on Dialysis. - NCT00442702-68114
Conditions: Anemia
Location: Omaha, NE
- A Study of Subcutaneous Mircera in Patients With Chronic Kidney Disease, Not on Dialysis. - NCT00442702-91344
Conditions: Anemia
Location: Granada Hills, CA
- A Study of Subcutaneous Mircera in Patients With Chronic Kidney Disease, Not on Dialysis. - NCT00442702-97045
Conditions: Anemia
Location: Oregon City, OR
- A Study of the Efficacy and Safety of Albiglutide in Subjects With Type 2 Diabetes With Renal Impairment. - NCT01098539-04401
Conditions: Diabetes Mellitus, Type 2 - Kidney Disease
Location: Bangor, ME
- A Study of the Efficacy and Safety of Albiglutide in Subjects With Type 2 Diabetes With Renal Impairment. - NCT01098539-27103
Conditions: Diabetes Mellitus, Type 2 - Kidney Disease
Location: Winston-Salem, NC
- A Study of the Efficacy and Safety of Albiglutide in Subjects With Type 2 Diabetes With Renal Impairment. - NCT01098539-28463
Conditions: Diabetes Mellitus, Type 2 - Kidney Disease
Location: Tabor City, NC
- A Study of the Efficacy and Safety of Albiglutide in Subjects With Type 2 Diabetes With Renal Impairment. - NCT01098539-29582
Conditions: Diabetes Mellitus, Type 2 - Kidney Disease
Location: North Myrtle Beach, SC
- A Study of the Efficacy and Safety of Albiglutide in Subjects With Type 2 Diabetes With Renal Impairment. - NCT01098539-29621
Conditions: Diabetes Mellitus, Type 2 - Kidney Disease
Location: Anderson, SC
- A Study of the Efficacy and Safety of Albiglutide in Subjects With Type 2 Diabetes With Renal Impairment. - NCT01098539-29651
Conditions: Diabetes Mellitus, Type 2 - Kidney Disease
Location: Greer, SC
- A Study of the Efficacy and Safety of Albiglutide in Subjects With Type 2 Diabetes With Renal Impairment. - NCT01098539-30076
Conditions: Diabetes Mellitus, Type 2 - Kidney Disease
Location: Roswell, GA
- A Study of the Efficacy and Safety of Albiglutide in Subjects With Type 2 Diabetes With Renal Impairment. - NCT01098539-30342
Conditions: Diabetes Mellitus, Type 2 - Kidney Disease
Location: Atlanta, GA
- A Study of the Efficacy and Safety of Albiglutide in Subjects With Type 2 Diabetes With Renal Impairment. - NCT01098539-30513
Conditions: Diabetes Mellitus, Type 2 - Kidney Disease
Location: Blue Ridge, GA
- A Study of the Efficacy and Safety of Albiglutide in Subjects With Type 2 Diabetes With Renal Impairment. - NCT01098539-32789
Conditions: Diabetes Mellitus, Type 2 - Kidney Disease
Location: Winter Park, FL
- A Study of the Efficacy and Safety of Albiglutide in Subjects With Type 2 Diabetes With Renal Impairment. - NCT01098539-32792
Conditions: Diabetes Mellitus, Type 2 - Kidney Disease
Location: Winter Park, FL
- A Study of the Efficacy and Safety of Albiglutide in Subjects With Type 2 Diabetes With Renal Impairment. - NCT01098539-33021
Conditions: Diabetes Mellitus, Type 2 - Kidney Disease
Location: Hollywood, FL
- A Study of the Efficacy and Safety of Albiglutide in Subjects With Type 2 Diabetes With Renal Impairment. - NCT01098539-35773
Conditions: Diabetes Mellitus, Type 2 - Kidney Disease
Location: Toney, AL
- A Study of the Efficacy and Safety of Albiglutide in Subjects With Type 2 Diabetes With Renal Impairment. - NCT01098539-37620
Conditions: Diabetes Mellitus, Type 2 - Kidney Disease
Location: Bristol, TN
- A Study of the Efficacy and Safety of Albiglutide in Subjects With Type 2 Diabetes With Renal Impairment. - NCT01098539-42003
Conditions: Diabetes Mellitus, Type 2 - Kidney Disease
Location: Paducah, KY
- A Study of the Efficacy and Safety of Albiglutide in Subjects With Type 2 Diabetes With Renal Impairment. - NCT01098539-45631
Conditions: Diabetes Mellitus, Type 2 - Kidney Disease
Location: Gallipolis, OH
- A Study of the Efficacy and Safety of Albiglutide in Subjects With Type 2 Diabetes With Renal Impairment. - NCT01098539-48126
Conditions: Diabetes Mellitus, Type 2 - Kidney Disease
Location: Dearborn, MI
- A Study of the Efficacy and Safety of Albiglutide in Subjects With Type 2 Diabetes With Renal Impairment. - NCT01098539-48235
Conditions: Diabetes Mellitus, Type 2 - Kidney Disease
Location: Detroit, MI
- A Study of the Efficacy and Safety of Albiglutide in Subjects With Type 2 Diabetes With Renal Impairment. - NCT01098539-73103
Conditions: Diabetes Mellitus, Type 2 - Kidney Disease
Location: Oklahoma City, OK
- A Study of the Efficacy and Safety of Albiglutide in Subjects With Type 2 Diabetes With Renal Impairment. - NCT01098539-75075
Conditions: Diabetes Mellitus, Type 2 - Kidney Disease
Location: Plano, TX
- A Study of the Efficacy and Safety of Albiglutide in Subjects With Type 2 Diabetes With Renal Impairment. - NCT01098539-77030
Conditions: Diabetes Mellitus, Type 2 - Kidney Disease
Location: Houston, TX
- A Study of the Efficacy and Safety of Albiglutide in Subjects With Type 2 Diabetes With Renal Impairment. - NCT01098539-77074
Conditions: Diabetes Mellitus, Type 2 - Kidney Disease
Location: Houston, TX
- A Study of the Efficacy and Safety of Albiglutide in Subjects With Type 2 Diabetes With Renal Impairment. - NCT01098539-77088
Conditions: Diabetes Mellitus, Type 2 - Kidney Disease
Location: Houston, TX
- A Study of the Efficacy and Safety of Albiglutide in Subjects With Type 2 Diabetes With Renal Impairment. - NCT01098539-77338
Conditions: Diabetes Mellitus, Type 2 - Kidney Disease
Location: Humble, TX
- A Study of the Efficacy and Safety of Albiglutide in Subjects With Type 2 Diabetes With Renal Impairment. - NCT01098539-77584
Conditions: Diabetes Mellitus, Type 2 - Kidney Disease
Location: Pearland, TX
- A Study of the Efficacy and Safety of Albiglutide in Subjects With Type 2 Diabetes With Renal Impairment. - NCT01098539-78215
Conditions: Diabetes Mellitus, Type 2 - Kidney Disease
Location: San Antonio, TX
- A Study of the Efficacy and Safety of Albiglutide in Subjects With Type 2 Diabetes With Renal Impairment. - NCT01098539-78222
Conditions: Diabetes Mellitus, Type 2 - Kidney Disease
Location: San Antonio, TX
- A Study of the Efficacy and Safety of Albiglutide in Subjects With Type 2 Diabetes With Renal Impairment. - NCT01098539-78751
Conditions: Diabetes Mellitus, Type 2 - Kidney Disease
Location: Austin, TX
- A Study of the Efficacy and Safety of Albiglutide in Subjects With Type 2 Diabetes With Renal Impairment. - NCT01098539-78758
Conditions: Diabetes Mellitus, Type 2 - Kidney Disease
Location: Austin, TX
- A Study of the Efficacy and Safety of Albiglutide in Subjects With Type 2 Diabetes With Renal Impairment. - NCT01098539-89106
Conditions: Diabetes Mellitus, Type 2 - Kidney Disease
Location: Las Vegas, NV
- A Study of the Efficacy and Safety of Albiglutide in Subjects With Type 2 Diabetes With Renal Impairment. - NCT01098539-90022
Conditions: Diabetes Mellitus, Type 2 - Kidney Disease
Location: Los Angeles, CA
- A Study of the Efficacy and Safety of Albiglutide in Subjects With Type 2 Diabetes With Renal Impairment. - NCT01098539-90603
Conditions: Diabetes Mellitus, Type 2 - Kidney Disease
Location: Whittier, CA
- A Study of the Efficacy and Safety of Albiglutide in Subjects With Type 2 Diabetes With Renal Impairment. - NCT01098539-91307
Conditions: Diabetes Mellitus, Type 2 - Kidney Disease
Location: West Hills, CA
- A Study of the Efficacy and Safety of Albiglutide in Subjects With Type 2 Diabetes With Renal Impairment. - NCT01098539-91356
Conditions: Diabetes Mellitus, Type 2 - Kidney Disease
Location: Tarzana, CA
- A Study of the Efficacy and Safety of Albiglutide in Subjects With Type 2 Diabetes With Renal Impairment. - NCT01098539-92648
Conditions: Diabetes Mellitus, Type 2 - Kidney Disease
Location: Huntington Beach, CA
- A Study of the Efficacy and Safety of Albiglutide in Subjects With Type 2 Diabetes With Renal Impairment. - NCT01098539-98405
Conditions: Diabetes Mellitus, Type 2 - Kidney Disease
Location: Tacoma, WA
- A Trial of Ferumoxytol for the Treatment of Iron Deficiency Anemia in Pediatric Subjects With Dialysis Dependent Chronic Kidney Disease - NCT01155375-02421
Conditions: Iron Deficiency Anemia
Location: Lexington, MA
- A Trial of Ferumoxytol for the Treatment of Iron Deficiency Anemia in Pediatric Subjects With Nondialysis-Dependent Chronic Kidney Disease - NCT01155388-02421
Conditions: Iron Deficiency Anemia - Nondialysis Dependent Chronic Kidney Disease
Location: Lexington, MA
- ADMA Levels in End-Stage Renal Disease - NCT00350974-48109
Conditions: Chronic Kidney Disease - Hypertension
Location: Ann Arbor, MI
- Aldosterone Breakthrough During Diovan, Tekturna, and Combination Therapy in Patients With Proteinuric Kidney Disease - NCT01129557-10032
Conditions: Proteinuric Kidney Disease - Diabetic Nephropathy - Hypertensive Nephrosclerosis - IGA Nephropathy - Focal Segmental Glomerulosclerosis - Glomerulopathy (Obesity-associated)
Location: New York, NY
- Alpha-Adrenoceptor Vascular Function In Chronic Kidney Disease Focus On The Role Of Endothelial Nitric Oxide - NCT00356265-48109
Conditions: Chronic Kidney Disease - Hypertension
Location: Ann Arbor, MI
- Analysis of Calcium Balance in Chronic Kidney Disease - NCT00974532-80045
Conditions: Chronic Kidney Disease
Location: Denver, CO
- Antibody Response to Human Papillomavirus Recombinant Vaccine (Gardasil®) in Girls and Young Women With Chronic Kidney Disease - NCT00806676-21287
Conditions: Chronic Kidney Disease
Location: Baltimore, MD
- Antibody Response to Human Papillomavirus Recombinant Vaccine (Gardasil®) in Girls and Young Women With Chronic Kidney Disease - NCT00806676-30322
Conditions: Chronic Kidney Disease
Location: Atlanta, GA
- Assessing Novel Methods of Improving Patient Education of Nutrition - NCT00394576-53713
Conditions: Chronic Kidney Disease
Location: Madison, WI
- Autosomal Dominant Polycystic Kidney Disease (ADPKD) Pain Study - NCT00571909-55905
Conditions: Kidney, Polycystic, Autosomal Dominant
Location: Rochester, MN
- Calcium and Phosphorus Balance and Calcium Kinetics in Patients With Stage 3/4 Chronic Kidney Disease - NCT01161407-46202
Conditions: Chronic Kidney Disease
Location: Indianapolis, IN
- Caregivers and Electronic Medication Monitoring in Chronic Kidney Disease - NCT01087255-02481
Conditions: Chronic Kidney Disease - Medication Adherence
Location: Wellesley, MA
- Carvedilol and Micro T-Wave Alternans in Hypertensives With Chronic Kidney Disease - NCT00638222-02903
Conditions: Vascular Disease - Kidney Disease
Location: Providence, RI
- Carvedilol and Micro T-Wave Alternans in Hypertensives With Chronic Kidney Disease - NCT00638222-43606
Conditions: Vascular Disease - Kidney Disease
Location: Toledo, OH
- Chewed vs. Crushed Lanthanum Carbonate in Hemodialysis Patients - NCT00660530-60612
Conditions: Hyperphosphatemia - Kidney Disease
Location: Chicago, IL
- Chronic Kidney Disease Antidepressant Sertraline Trial - NCT00946998-75216
Conditions: Chronic Kidney Disease - Depression
Location: Dallas, TX
- Clinical and Basic Investigations Into Hermansky-Pudlak Syndrome - NCT00001456-20892
Conditions: Albinism - Intestinal Disease - Kidney Disease - Myocardial Disease - Pulmonary Fibrosis
Location: Bethesda, MD
- Clinical Phenotyping Resource and Biobank Core of the Michigan O'Brien Renal Center - NCT01016613-48109
Conditions: Chronic Kidney Disease - Glomerulopathy
Location: Ann Arbor, MI
- Clinical Phenotyping Resource and Biobank Core of the Michigan O'Brien Renal Center - NCT01016613-48201
Conditions: Chronic Kidney Disease - Glomerulopathy
Location: Detroit, MI
- Clinical Phenotyping Resource and Biobank Core of the Michigan O'Brien Renal Center - NCT01016613-48236
Conditions: Chronic Kidney Disease - Glomerulopathy
Location: Detroit, MI
- Clinical Phenotyping Resource and Biobank Core of the Michigan O'Brien Renal Center - NCT01016613-60612
Conditions: Chronic Kidney Disease - Glomerulopathy
Location: Chicago, IL
- Comparison of Dialysis Therapies on Cognitive Function - NCT00597103-94041A
Conditions: End Stage Renal Disease - Chronic Kidney Disease
Location: Mountain View, CA
- Comparison of Dialysis Therapies on Cognitive Function - NCT00597103-94041B
Conditions: End Stage Renal Disease - Chronic Kidney Disease
Location: Mountain View, CA
- Defining The Role Of Dialysate Magnesium In Arrhythmogenicity On Dialysis - NCT00242164-48104
Conditions: Hemodialysis - Chronic Kidney Disease - Arrhythmia
Location: Ann Arbor, MI
- Defining The Role Of Dialysate Magnesium In Arrhythmogenicity On Dialysis - NCT00242164-48152
Conditions: Hemodialysis - Chronic Kidney Disease - Arrhythmia
Location: Livonia, MI
- Determination of Kidney Function - NCT00001978-20892
Conditions: Kidney Disease
Location: Bethesda, MD
|
|
|
|
|
Didn't find what you were looking for? Try these alternatives:
Become A Member: To be notified of upcoming clinical trials in your
area please create a free member account.
Browse Studies: If you would like to browse all featured clinical trials
please Browse Studies.
Message Board: Join the discussion in our Health
and Clinical Trials Message Board.
|
|
|